The Role of Vitamin D and Oxidative Stress in Chronic Kidney Disease.

Published online

Journal Article

Chronic kidney disease (CKD) is a major non-communicable disease associated with high rates of premature morbidity and mortality. The prevalence of hypovitaminosis D (deficiency of 25(OH)D or 25D) is greater in racial/ethnic minorities and in patients with CKD than the general population. Low 25D is associated with bone and mineral disorders as well as immune, cardiometabolic and cardiovascular (CV) diseases. Thus, it has been suggested that low 25D contributes to the poor outcomes in patients with CKD. The prevalence of hypovitaminosis D rises progressively with advancing severity of kidney disease with over 30% of patients with CKD stage 3 and 70% patients with CKD stage 5 estimated to have low levels of 25D. This report describes several of the abnormal physiologic and counter-regulatory actions related to low 25D in CKD such as those in oxidative stress and inflammatory systems, and some of the preclinical and clinical evidence, or lack thereof, of normalizing serum 25D levels to improve outcomes in patients with CKD, and especially for the high risk subset of racial/ethnic minorities who suffer from higher rates of advanced CKD and hypovitaminosis D.

Full Text

Duke Authors

Cited Authors

  • Norris, KC; Olabisi, O; Barnett, ME; Meng, Y-X; Martins, D; Obialo, C; Lee, JE; Nicholas, SB

Published Date

  • November 30, 2018

Published In

Volume / Issue

  • 15 / 12

PubMed ID

  • 30513574

Pubmed Central ID

  • 30513574

Electronic International Standard Serial Number (EISSN)

  • 1660-4601

Digital Object Identifier (DOI)

  • 10.3390/ijerph15122701

Language

  • eng

Conference Location

  • Switzerland